All Janssen has to do is make an extended release form in the right dose
for improving lactation, and then submit it as a substantial
improvement.  Voila, new patent.  US manufacturers do it all the time!
Tegretol (carbamazepine- an anticonvulsant)--Tegretol XR (extended
release carbamazepine through an indigestible tablet with a pinhole to
let the drug out in controlled amounts)--Carbatrol (extended release
carbamazepine by controlled dissolution) and finally Trileptal
(oxcarbamazepine - adding that tiny group totally changes metabolism of
the drug, avoiding the most problematic metabolite (carbamazepine
epoxide) in terms of side effects, without reducing the effectiveness of
the drug.)
I certainly think it would be worth their money, or anyone else's.
Catherine Watson Genna, BS, IBCLC  NYC

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html